Immune infiltrates as predictive markers of survival in pancreatic cancer patients.
about
From bench to bedside a comprehensive review of pancreatic cancer immunotherapy.Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancerBeyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgeryA randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.Impact of Intratumoral Inflammation on Survival After Pancreatic Cancer Resection.Serglycin: at the crossroad of inflammation and malignancy.Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.Stromal biology and therapy in pancreatic cancer: a changing paradigm.Targeting cancer cell metabolism in pancreatic adenocarcinoma.T cell optimization for the treatment of pancreatic cancer.Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment.CD4(+) T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells-novel implications of CD4(+) T cells in pancreatic cancer development.The pancreatic cancer microenvironment: A true double agent.Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.M1 and M2: there is no "good" and "bad"-How macrophages promote malignancy-associated features in tumorigenesisExtracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer.Increased number of non-degranulated mast cells in pancreatic ductal adenocarcinoma but not in acute pancreatitis.Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages.Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment.A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity.Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer.Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future OptionsKRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic CancerRisk factors for pancreatic cancer: underlying mechanisms and potential targets
P2860
Q26765123-E1D22D05-E172-412D-B69F-E3A2D099CD75Q26853171-C3557DB2-11BD-4EF3-9D18-D1EB2434338DQ30276874-651A9D85-180A-4E81-8546-4B7FFBB14BE3Q33567742-BC7356EE-AA39-4D38-A799-61ACDBE86D9CQ33786751-9B0152D8-F3BE-497C-BE30-5B3BE61736CCQ35892017-4D09B124-141B-42DA-8535-F706C6F11F4AQ35936030-D07EA571-3770-44A4-86AD-9998E8E3C08FQ36850566-4BE5BF21-3F5C-464C-AA0E-688634B2D9A4Q37467048-291A74BC-F3AE-4DE5-B022-33FC637342ABQ37617957-DA0A5F6D-6627-446C-91E5-F3A73D60B7FCQ38494338-3A788CFF-F4BE-415F-A6A7-46A54CF8FA8CQ38545275-43645182-6A58-4670-972F-C2A867BE5D1DQ38638035-2DFB293D-935C-4BB6-BE98-4C179D2B64EDQ38650250-13C940ED-A946-4E72-B6F0-7FC3288E29E3Q38857263-851E6D43-C4A5-4134-BCE0-63020E9A5B96Q39366753-EB4288A2-6525-42D0-86EE-7C6096551433Q41153247-3A0FCE42-1F5C-43BF-B39B-4DD881B41477Q42028874-C55F2FF6-4F27-4B38-B7C7-2AD9A2FA2255Q48141138-92F88065-54B7-4B25-B57B-06F0699BDB8BQ50426404-2D531FEB-DA09-4F1E-8D1A-F0F93013B775Q53646506-D9E22301-459B-4B6D-8267-E1FD9D3BC84CQ55080593-08ECB204-593F-4F92-9304-71C4D1732BEEQ55333132-66D47AB9-B45F-431C-96D9-CCF61715A07FQ55518017-F8658378-7444-4429-86D8-43E5133DF936Q56890107-494B5306-7446-4D6E-B447-BA4B025F07BAQ57072901-C45CA780-A0BF-4117-9C26-360A64CD2E79Q58563303-51D567D3-4932-4684-8FAE-B2E6E520189C
P2860
Immune infiltrates as predictive markers of survival in pancreatic cancer patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune infiltrates as predictive markers of survival in pancreatic cancer patients.
@en
type
label
Immune infiltrates as predictive markers of survival in pancreatic cancer patients.
@en
prefLabel
Immune infiltrates as predictive markers of survival in pancreatic cancer patients.
@en
P2860
P356
P1476
Immune infiltrates as predictive markers of survival in pancreatic cancer patients.
@en
P2093
Lucia De Monte
P2860
P356
10.3389/FPHYS.2013.00210
P577
2013-08-09T00:00:00Z